PREVENTION OF PNEUMOCOCCAL INFECTION BY IMMUNIZATION WITH CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS-PNEUMONIAE - CURRENT STATUS OF POLYVALENT VACCINES

被引：71
作者：
AUSTRIAN, R [1 ]
机构：
[1] UNIV PENN,SCH MED,DEPT RES MED,PHILADELPHIA,PA 19174
来源：
JOURNAL OF INFECTIOUS DISEASES | 1977年 / 136卷
关键词：
D O I：
10.1093/infdis/136.Supplement.S38
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S38 / S42
页数：5
相关论文
共 50 条
[41]   Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection [J].
Nagai, Kosuke ;
Domon, Hisanori ;
Maekawa, Tomoki ;
Hiyoshi, Takumi ;
Tamura, Hikaru ;
Yonezawa, Daisuke ;
Habuka, Rie ;
Saitoh, Akihiko ;
Terao, Yutaka .
VACCINE, 2019, 37 (01) :160-168
[42]   Immunization with pneumococcal polysaccharide SSS-3 and lipopolysaccharide protects against deadly Streptococcus pneumoniae infection in mice [J].
Restori, Katherine ;
Kennett, Mary ;
Ross, A. .
JOURNAL OF IMMUNOLOGY, 2012, 188
[43]   STUDY OF THE MODE OF ACTION OF RIBOSOMAL VACCINES FROM KLEBSIELLA AND STREPTOCOCCUS-PNEUMONIAE AND THEIR RIBONUCLEIC AND PROTEIN-FRACTIONS USING PASSIVE-IMMUNIZATION [J].
ROBERT, D ;
IVANOFF, B ;
FONTANGES, R ;
NORMIER, G ;
PINEL, AM ;
DHINTERLAND, LD .
MICROBIOLOGY AND IMMUNOLOGY, 1982, 26 (10) :933-940
[44]   Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines (vol 502, 108277, 2021) [J].
Javed ;
Mandal, Pintu Kumar .
CARBOHYDRATE RESEARCH, 2021, 504
[45]   Experimental padre-carbohydrate vaccines composed of the universal helper T-lymphocyte epitope (PADRE) and streptococcus pneumoniae capsular polysaccharides [J].
Alexander, J ;
del Guercio, MF ;
Stewart, B ;
Maewal, A ;
Beebe, M ;
Nahm, MH ;
Newman, MJ .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 :U268-U268
[46]   Pectic Polysaccharides Isolated from Malian Medicinal Plants Protect against Streptococcus pneumoniae in a Mouse Pneumococcal Infection Model [J].
Inngjerdingen, K. T. ;
Langerud, B. K. ;
Rasmussen, H. ;
Olsen, T. K. ;
Austarheim, I. ;
Gronhaug, T. E. ;
Aaberge, I. S. ;
Diallo, D. ;
Paulsen, B. S. ;
Michaelsen, T. E. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (05) :372-388
[47]   STREPTOCOCCUS-PNEUMONIAE POLYSACCHARIDE VACCINE - AGE AND DOSE RESPONSES, SAFETY, PERSISTENCE OF ANTIBODY, RE-VACCINATION, AND SIMULTANEOUS ADMINISTRATION OF PNEUMOCOCCAL AND INFLUENZA VACCINES [J].
HILLEMAN, MR ;
CARLSON, AJ ;
MCLEAN, AA ;
VELLA, PP ;
WEIBEL, RE ;
WOODHOUR, AF .
REVIEWS OF INFECTIOUS DISEASES, 1981, 3 :S31-S42
[48]   STATUS OF STREPTOCOCCUS-PNEUMONIAE RESISTANCE TO PENICILLIN-G IN CURRENT BACTERIOLOGICAL EPIDEMIOLOGY OF OTITIS-MEDIA IN CHILDREN [J].
GARABEDIAN, EN ;
BELLITY, A ;
TASHJIAN, G ;
GHIASSI, B ;
THIEN, HV ;
BEGUE, P .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 :674-680
[49]   Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae [J].
LS McDaniel ;
F Loechel ;
C Benedict ;
T Greenway ;
DE Briles ;
RM Conry ;
DT Curiel .
Gene Therapy, 1997, 4 :375-377
[50]   Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae [J].
McDaniel, LS ;
Loechel, F ;
Benedict, C ;
Greenway, T ;
Briles, DE ;
Conry, RM ;
Curie, DT .
GENE THERAPY, 1997, 4 (04) :375-377
12345